HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Condition: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Interventions: Drug: Vutrisiran; Drug: Sterile Normal Saline (0.9% NaCl) Sponsor: Alnylam Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials